1Frank S, Braonwald E:Idiopathic hypertrophic subaortic stenosis:Clinical analysis of 126 patients with emphasis on the natural history.Circulation 1968,37:759-788.
2Wigle ED,Sasson Z,Henderson MA,et al:Hyertrophyic cardiomyopathy:The importance of the site and the extent of hypertrophy-A review.Prog Cardiovasc Dis 1985,28:1-83.
3Maron BJ,Bonow RO,Cannon RO III,et al:Hypertrophic cardiomyopathy:Interrelations of clinical manifestations.pathophysiology.and therapy.N Engl J Med 1987,316:780-789 and 844-852.
4Maron BJ,Gardin JM,Flack JM.et al:Prevalence of hypertrophic cardiomyopathy in a general population of young adults:Echocardiographic analysis of 4111 subjects in the CARDIA study.Circulation 1955,92:785-789.
5Watkins H,Rosenzwieg A,Hwang DS,et al:Characteristies and prognostic implications of myosin missense mutations familial hypertrophic cardiomyopathy.N Ehgl J Med 1992,326:1108-1114.
6Watkins H,McKenna WJ,Thierfelder L.et al:The role of cardiac troponin T and a Iropomyosin mutations in hypertrophc cardiomyopathy.N Engl J Med 1995,332:1058-1064.
7Watkins H,Conner D,Thierfelder L,et al:Mulations in the cardiac myosin binding protein-C gene on chromo some 11 cause familial hypertrophic cardiomyopathy.Nat Genet 1995,11:434-437.
8Bonne G,Carrier L,Bercovici F.et al:Cardiac myosin binding protein-C.gene splice acceplor site mutation is associated with familial hypertrophic cardiomyopathy.Nat Genet 1995,11:438-440.
9Poetter K,Jiang H,Hassanzadeh S,et al:Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathe in human heart and skeletal musele.Nat Genet 1996,13:63-69.
10Spirito P,Seidman CF.,MeKenna WJ,et al:The management of hypertrophic cardiomyopathe.N Engl J Med 1997,336:775-785.
